Brainstorm Cell Therapeutics shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Brainstorm Cell Therapeutics by GSA Capital Partners
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $63k | 111k | 0.57 |
2021-09-30 | $568k | 172k | 3.30 |
2021-06-30 | $229k | 60k | 3.80 |
2021-03-31 | $97k | 25k | 3.83 |
2020-03-31 | $58k | 13k | 4.64 |